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INTRODUCTION 
          Pediatric functional gastrointestinal disorders (FGIDs) include conditions in which a variable 
combination of often, age-dependent, chronic, or recurrent symptoms, such as vomiting, 
constipation, abdominal pain, are not explained by structural or biochemical abnormalities.    
As the child is programmed to develop, some functional disorders which occur during childhood 
accompany normal development, or may triggered by age appropriate but maladaptive behavioral 
response to internal or external stimuli. According to a biopsychosocial conceptualization of the 
pathogenesis and clinical expression of the FGIDs, early in life and genetics, in addition to 
environmental factors such as family influences on illness expression, abuse, major losses, or 
exposure to infections, may affect one’s psychosocial development in terms of one’s susceptibility 
to life stress or psychological state and coping skills, as well as susceptibility to gut dysfunction, 
abnormal motility, altered mucosal immunity, or visceral hypersensitivity. Furthermore, these 
“brain-gut” variables reciprocally influence their expression. Therefore,  FGIDs are the clinical 
product of this interaction of psychosocial factors and altered gut physiology via the brain-gut axis 
(1). 
Genetic factors may predispose some individuals to develop FGIDs, whereas in others, 
environmental factors contribute to the phenomic expression of these conditions, as well as patient 
attitudes and behaviours (including health care seeking) relating to it. Some infants may inherit a 
genetic susceptibility to FGIDs characterized by a particular gastrointestinal reactivity to stress. 
This temperament-sensitive reactivity seems to be associated to other biological systems such as the 
cardiovascular, neuroendocrine and immunologic (2). Several pathways may be involved in this 
genetic predisposition, including lower levels of IL-10 (an anti-inflammatory cytokine) in some 
patients with IBS (3) that may effect gut mucosal neural sensitivity, serotonin reuptake transporter 
polymorphisms that can effect levels of 5-HT neurotransmitter, or the response to 5-HT blocking 
agents (4,5) g-protein polymorphisms that can affect both CNS and gut-related actions (6) and  2-
adrenoreceptor polymorphisms that affect motility (7). Serotonin reuptake transporter 
polymorphisms have effects on mood disturbances (8) and may be a genetic link to disorders of 
brain-gut function such as IBS. This represents an interesting area for future studies. 
The aggregation of FGIDs in families (9) is not only genetic. Also environmental factors 
during early life may play a role in the development of FGIDs. Plasticity of the neonatal brain 
allows early life events to program physiologic response to stress during infancy that may be 
perpetuated into adulthood (10). Furthermore, what children learn from parents may contribute to 
the risk of developing an FGID(11, 12) In fact, children of adult patients with IBS make more 
health care visits (and incur more health care costs) than children of non-IBS parents (13,14), so the 
family should be aware about the role that psychosocial factors play in the development and 
perpetuation of FGIDs. 
Nevertheless psychosocial factors do not define the FGIDs and are not required for 
diagnosis, research in this field yields three general observation: 1) psychological stress exacerbates 
GI symptoms; 2) psychosocial factors modify the experience of illness and illness behaviours such 
as health care seeking; 3) a functional gastrointestinal disorder may have psychosocial 
consequences on one’s general well-being, daily function status, one’s sense of control over the 
symptoms, in one word on one’s quality of life. 
Patients with FGDIs often exhibit sensory afferent dysfunction of the digestive tract that is 
manifested as altered sensitivity to luminal distention or other stimuli, and that selectively affects 
the visceral territory (15). Sensation and motility represent the two aspects of gut physiology most 
relevant to the FGIDs. In health, physiological stimuli from the gut induce motor reflexes, but these 
remain largely unperceived, with the exception of those related to ingestion and excretion. 
Depending on specific organs affected, visceral hypersensitivity may underline common symptoms 
in the FGIDs such as chest pain, abdominal discomfort, abdominal bloating, urgency defecation. 
Gut sensitivity is intimately related to gut motility. Sensory and motor functions of the 
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gastrointestinal tract are mediated through the enteric nervous system (ENS) and through the 
extrinsic nerves that connect the gastrointestinal tract to the central nervous system. 
The major functions of human digestive tract motility are to accomplish propulsion along 
the gut, to mix gut contents with digestive secretions and expose them to the absorptive surface, to 
facilitate temporary storage in certain regions of the gut, to prevent retrograde movement of 
contents from one region to another, and to dispose of residues. Motility is controlled by reflexes, 
both central and peripheral, as well as by descending modulation from the brain-gut axis. 
Communication between various regions of the gut is facilitated by the transmission of myogenic 
and neurogenic signals longitudinally along the gut (16). Gastrointestinal contractions may be 
classified on the basis of their duration; contractions may be of short duration (phasic contractions) 
or may be more sustained (tone).  
Tone is clearly recognized in organs with reservoir function, such as the proximal stomach 
(accommodation response to a meal) and the colon (response to feeding), as well as in sphincter 
regions. 
Compliance refers to the capability of a region of the gut to adapt to its content; it is 
expresses as the ratio of the change in volume to the change in pressure and is obtained from the 
pressure-volume curve. Compliance reflects the contribution of several factors, including the 
capacity (diameter) of the organ, the resistance of surrounding organs, the elastic properties of the 
gut wall, and its muscular activity. Wall tension, related to compliance, describes the force acting 
on the gut wall and results from the interaction between intraluminalcontent and the elasticity of the 
wall. 
 Gut sensation is influenced by tonic or phasic contractions, and several observations 
suggest that this is mediated in part by an effect on wall tension; assessment of wall tension is 
therefore important in the interpretation of results of tests assessing perception of visceral stimuli. 
Transit refers to the time taken for intraluminal contents to traverse a specified region of the 
gastrointestinal tract. It reflects the combined effects of the various phenomena outlined earlier. 
Most measurements of transit are based on detecting intraluminal movements of an extrinsic marker 
labelling the luminal content. Transit depends on many factors, such as the physical (eg, solid, 
liquid, and gas) and chemical (eg, pH, osmolality, and nutrient composition) nature of both gut 
contents and the administered marker. Measurement of transit is influenced by the state of gut 
motility at the time of marker administration (eg, fasted vs fed motility) and any preparation of the 
gut (eg, cleansing of the colon). Some symptoms characteristic of the FGIDs, such as constipation 
and diarreha, are suggestive of dysmotility including alteration in contractile activity, tone, 
compliance and transit in various regions of the GI tract. 
In the context of the FGIDs, gastrointestinal dysmotility can develop through dysfunction of 
the control mechanisms at any level from the gut to the CNS. For example, inflammatory, immune, 
infiltrative, degenerative, or other processes may directly affect the muscle and/or other elements of 
the enteric nervous system,whereas psychosocial stressors can induce profound alterations in 
motility (17-26). Because patients with FGID tend to have a greater gastrointestinal motor response 
to stressful conditions than do healthy subjects, psychosocial stressors are particularly relevant to 
the symptomatic manifestations of the FGIDs (27-31). 
In the FGIDs, sustained and inappropriate gut hypersensitivity, as well as gut dysmotility, 
are well documented. These sensory-motor dysfunctions seem related to alterations in neural 
processing in the brain-gut axis and in visceral reflex pathways. Their underlying causes and their 
relevance to symptom generation are the subject of ongoing research. 
 
          Despite recent progress in our understanding of pathophysiologic mechanisms underlying 
some forms of FGIDs, no biologic marker exists yet to allow a final diagnosis of FGID. Without 
any anatomic or biochemical labels, the FGID have required a classification based solely on 
symptoms.  
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In 1997, a pediatric working team met in Rome to standardize diagnostic criteria for various FGIDs 
in Children.  The pediatric Rome II criteria  for FGIDs were published for the first time in 1999 
(32). Instead of classifying disorders according to target organs, as in the adult population, the 
pediatric working team divided disorders according to main complaints reported by children or their 
parents. The diagnoses were divided into 4 categories according to the following symptoms: 
vomiting, abdominal pain, diarrhea, and disorders of defecation.  The Rome II criteria did not 
represent an end-point but a starting point to enhance new well-designed studies with the aims of 1) 
screening large populations to show that these diseases exist across time and cultures; 2) 
determining if the symptom based criteria are accurate in separating children with functional 
disorders from those with disease. However, although this publication generated scientific interest 
and contributed to the recognition of these disorders as diagnostic entities, a limited number of 
studies as been published since (33-42).  
Recently, Caplan et al (33) developed the Questionannaire on pediatric GI symptoms (QPGS).  The 
QPGS was designed as a both a parent report and child self-report measure based on the pediatric 
Rome II criteria for FGID.  It was constructed in English, translated into French and pilot tested in 
both languages.  The conclusion of the study was that the QPGS parent report is a valid and reliable 
measure for children 4 to 9 years old.  For children 10 to 18, the QPGS child report is more reliable 
and should be used whenever possible. The same group of Authors examined the validity of the 
Pediatric Rome II criteria using the QPGS as  reliable measure of GI symptoms for the different age 
group and found that more than half of patients classified as having a functional problem met at 
least one pediatric Rome II diagnosis for FGID (34). Subsequently, Di Lorenzo C et al (43) reported 
that the interobserver reliability of  the Rome II criteria among pediatric gastroenterologist and 
fellow were low and that further validation of the criteria were necessary. More user friendly 
criteria probably needed to be developed in order to enhance their diagnostic accuracy and clinical 
utility. A possible explanation is that as fellows have less clinical experience, they may have 
adhered more closely to the criteria, while some of the specialist may have used it more loosely or 
may have applied their clinical experience to establish the diagnosis of the cases without consulting 
the criteria. This study supported the findings of previous investigations that the criteria were too 
restrictive and exclusive of many cases of  specific FGIDs in children  as reported by previous 
studies (35,40,41). 
The above-mentioned publications have offered valid criticism of some disorders and 
provided preliminary validation of others and all this represented an appropriate background for the 
Rome III criteria (44, 45).  The revised version of the Rome criteria has separated the pediatric 
criteria in two groups, based on an arbitrary division between  infants/toddlers, and 
child/adolescent.  
Rome III criteria has been revised in order to make diagnostic criteria more applicable 
to clinical practicewith the following end points: better care for children; better research 
to understand the genetic,developmental, familial and cultural componentsof these 
disorders. 
 
This document includes papers published or in press that have explored the interesting field of 
FGIDs and gastrointestinal motility in children.  We  started with the evaluation of the development of 
esophageal and gastrointestinal motility in humans in order to obtain information about the normal 
physiology of the gastrointestinal tract. In this way, indirectly, we aimed to better understand the 
possible pathophysiologic mechanisms that underline FGIDs and targets for more tailored therapeutic 
interventions. In the second chapter we studied the epidemiology of two specific FGIDs, the 
gastroesophageal reflux (GER) and the disorders of defecation, in unselected populations of children. 
In addition, in the first study we evaluate the natural history of GER in infants followed for the first 
two years of life; while in the second study we evaluate the clinical applicability and validity of the 
new pediatric Rome III criteria for functional defecation disorders. In the same chapter a third clinical 
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trial has examined  the relation among the pathopysiology of two specific FGIDs, functional dyspepsia 
(FD)  and functional constipation (FC).  
On the contrary, the third chapter contains four papers addressing to the following arguments of 
diagnosis and therapy :  1) the validity and applicability of a new tool for the study of esophageal 
motility in children: the high resolution manometry; 2) the temporal correlation between chronic 
chough and GER and the role of esophageal pH-metry and the symptomatic indices: the traditional 
symptom (SI) and symptom sensitivity (SSI) indices vs the new symptom association probability 
(SAP); 3) the usefulness of maintenance therapy for gastroesophageal reflux disease in children and 
finally; 4) the correlation between migraine and FGIDs and the efficacy of flunarizine in migainous 
children affected by FGIDS. 
 
 
 
 
 
 
 
 
 
 
 
-How did we get to Rome? 
Annamaria Staiano, Gabriella Boccia. 
J Pediatr Gastroenterol Nutr 2005;41:S28-29 
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CHAPTER 1 
ONTOGENY AND NORMAL PHYSIOLOGY OF THE ESOPHAGEAL AND 
GASTROINTESTINAL MOTILITY. 
 
- Annamaria Staiano; Gabriella Boccia. Development of motility. In: Feeding during late infancy 
and early childhood: impact on health. Hernell O, Schmitz J eds. Nestlè Nutr Workshop Ser Pediatr 
Program, 2005; 56:85-98. 
 
- Gabriella Boccia, Annamaria Staiano. Intestinal motility: Normal Motility and Development of 
the Intestinal Neuroenteric System. In: RE Kleinman, O-J Goulet eds.Walker’s Pediatric 
gastrointestinal disease. Patophysiology, diagnosis, management (Fifth edition, in press). 
 
- Annamaria Staiano, Gabriella Boccia, Gennaro Salvia, Donato Zappulli, Ray E Clouse. 
Development of Esophageal Peristalsis in Preterm and Term Neonates. Gastroenterology 
2007;132:1718–1725 
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Introduction 
Advance in neonatology over the past 2 decades have resulted in survival of very preterm 
infants.  However, the major limiting factor for survival of such infants is now the ability to initiate 
and maintain adequate nutrition. 
Multiple maturational events are necessary for successful enteral nutrition of the infant : 
coordination of sucking and swallowing; effective gastric emptying; forward propagation of small 
intestinal contents and, finally, colonic elimination.  Since normal gastrointestinal function relies on 
the integrated maturation of absorbitive, secretory and motor function, a delay in any one of these 
processes will result in disturbed gastrointestinal function.  Immature gastrointestinal motility 
manifested by vomiting, abdominal distention, delay in stooling and constipation commonly 
pospone the time of full enteral feeding in premature infants. 
Recent advances in biomedical engineering have allowed the study of gastrointestinal 
motility even in very premature infants.  By using miniaturized feeding catheters with an outer 
diameter of less than 2 mm, multiple  recording sites and sleeve sensors and with rates of water 
infusion ranging between 0.005 to 0.04 ml/min, we have learnt a great deal about the functional 
ontogeny of esophageal and antroduodenal motility in humans.  In contrast, due to the difficulty to 
study the human colon in physiologic condition, very little is known about the development of 
colonic motility.  Placement of manometric or barostat catheters in the colon requires endoscopy 
and cannot be justified in healthy infants while non-invasive techniques such as scintigraphic transit 
studies or ultrasonographic evaluations have not been standardized yet in children. 
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Development of myogenic control 
The fetal development of the structure and function of the gastrointestinal tract is a complex 
process.  Throughout the intestine, three layers of muscle contract in a coordinated fashion: the 
muscularis mucosa, a thin layer that lies beneath the villi; the circular muscle, wich lies outside of 
the muscularis mucosa and serves as the pacemaker for gut muscle contraction; and the longitudinal 
muscle, the most outer layer of the three muscles. These muscles have oscillatory membrane 
potentials and their contraction rate is reflective of the electrical slow waves.  The slow wave has 
different frequency at each level of the gut (i.e., 3 to 5 time per minute in the stomach, 9 to 11 time 
per minute in the duodenum, 8 to 10 times per minute in the jejunum and so forth).  Thus, at each 
level of the gut, there is an intrinsic phasic contraction rate. 
The muscular layers derive from the mesenchymal tissue in the gut by the 4th to the 6th week 
of gestation in a rostral caudal fashion (1).  The circular muscle layer appears first, followed, after  
2 to 3 weeks, by the longitudinal muscle coat, while the muscularis mucosa is formed later, by 22 to 
23 weeks gestation.  Similarly, the contractile proteins of smooth muscle cells in animal models 
appear in a hierarchic manner; however, no such information is available in humans (2). Just as the 
developmental changes of the contractile proteins occur, the frequency of the slow waves or electric 
control activity (ECA) of the smooth muscle cells also changes.  The frequency of ECA increases 
with the  increasing of  postconceptional age, reflecting developmental changes in the activity of 
membrane iron pumps or in their modulation (3). 
Until recently, some investigators suggested that groups of  muscle cells located in the 
circular layer differentiated to form the interstitial cell of Cajal (ICCs), specialized cells provided of 
multiple processes that projects in an ascending and descending manner throughout the length of the 
circular muscle and to the longitudinal muscle.  These cells act as pacemakers by driving the slow 
wave frequency and coordinate neural input to gut smooth muscle (4).  The ICCs are distinct from 
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neurons and smooth muscle cells, and they play important roles in the regulation of gastrointestinal 
motility.  
Anatomic studies characterizing the distribution of ICCs measure immunoreactivity to c-Kit, 
a proto-oncogene coding for a receptor tyrosine kinase.  Six distinct ICCs population were 
identified in the gut, including intramuscolar ICCs, ICCs within the myenteric plexus, submucosal 
ICCs in the colon and ICCs in the deep muscular plexus of the small intstine.  A recent study has 
reported regional variability in colonic ICC density with the highest numbers observed in the 
transverse colon (5). 
ICCs are present from an early stage in human gut development.  Intrauterin maturation of 
ICCs correlates with the initiation of electrical rhytmicity, in fact in mutant mice lacking ICCs, no 
spontaneous pacemaker activity is seen (6).  Such loss of pacemaker function leads to distruption of 
organized luminal propagation.  
Recent studies have reported that a delayed maturation of  ICCs could be involved in the 
pathophysiology of gastrointestinal dismotility seen in some neonates and children (7-8) and 
abnormalities in the density and distribution of ICCs have been described in human Hirschsprung 
disease and infantile hypertophic pyloric stenosis (9-10).  However, since ICCs development 
continues well into postnatal life, interpretation of  apparent abnormalities in their distribution as 
being of pathological significance should be tempered.  
The finding that c-kit positive ICCs are present from 9.5 weeks when neural crest 
colonization of the gut is approching completion, is consistent with a modulating effect of the fetal 
enteric nervous system (ENS)  on ICCs development. 
 
Development of neurogenic control 
Initiation and coordination of muscle contraction is regulated by neural and hormonal input. 
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Extrinsic neural regulation refers to all nerves that have cell body located outside of the intestinal 
tract. Extrinsic neural input to the gastrointestinal tract comes from the central nervous system 
(CNS, the sympathetic and the parasympathetic systems.  Intrinsic  neural regulation refers to all 
nerves whose cell bodies reside in the intestine.  The enteric nervous system (ENS), or gut brain, 
provides most of this regulation.  It is capable of functioning indipendently of the exstrinsic nervous 
system in animals when connections to the extrinsic nerves have been served (1).  
Components of the ENS are formed in a temporal sequence that parallels the maturation of 
the muscle layers.  Neural crest cells migrate out to the intestine via the vagal and sacral portion of 
the spinal cord.  The indifferentiated cells are first detected in the stomach and duodenum at 7 
weeks and than in the rectum at 12 weeks.  They quickly differentiate along a rostral caudal axis 
and establish the myenteric and submucosal  plexuses by week 12 to 14.  Contacts between enteric 
nerves and the circular and longitudinal muscle cells develop between 10 and 26 weeks (11).  It 
appears that there is intimate cross talk between the developing muscle and nerves and if either of 
the two fail to develop properly, maturation of the other is arrested .  
Several observations suggest that development of the enteric nervous system continues after 
birth and through at least the first 12 to 18 months of life.  Study of the argyrophilia of neurons in 
the sigmoid colon of human neonates shows that, prior to term, nerves are unable to take up silver 
and that, during the first 6 months of life, neurons in the myenteric plexus gradually assume 
argyrophilia (12).  Thus evidence suggests that, just the majority of CNS development takes place 
through fetal life and continues through the first 18 months of life, a similar pattern occurs in ENS. 
Neurotransmitters are elaborated by the end of first trimester  as almost all of the hormones 
and peptides.  N-methyl-D aspartate (excitatory) and nitric oxide (inhibitory) have been shown to be 
neurotransmitters in animal studies and may be the most potent agents in modulating bowel motility 
(13). 
Recent studies have indicated that nitric oxide is involved in the non adrenergic-non 
cholinergic (NANC) innervation of the gut, mediating its relaxation.  Brandt et al. (14) reported that 
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the onset and place of development of nitrergic innervation are similar to adrenergic and cholinergic 
innervation and occur before peptidergic innervation.  Bowel segments from the esophagus, 
pylorus, ileocecal and rectosigmoid regions of 14 fetus (gestational age range from 12 to 23 weeks) 
were studied with nicotinamide adenosine dinucleotide phosphate (NADPH) diaphorase 
histochemestry.  By 12 weeks gestation, nitrergic neurons had appeared in the myenteric ganglia, at 
all level of the gut, and had begun plexus formation.  Nitrergic innervation of the submucous plexus 
becames evident after 14 weeks.  By 23 weeks gestation a complete nitrergic pattern,  as observed 
in the postnatal gut, had maturated.  
These NANC nerves mediate the reflex opening of sphincters in the alimentary tract and the 
descending inhibition during intestinal peristalsis.  Defects of nitrergic innervation recently have 
been found in congenital gut anomalies such as pyloric stenosis and Hirschsprung’s disease, which 
suggests that a lack of nitric oxide-mediated NANC inhibitory control may be responsible for the 
failure of relaxation of the pylorus and hindgut, respectively (15). 
The combined maturation of the enteric and central nervous system, together with their 
interconnections, is likely to be resposible for many of the mayor ontogenetic changes observed in 
intestinal motor activity before and after birth.  
 
Characterization of motor activity 
Gastric motility 
Many aspects of  gastrointestinal motility appear to be less mature in the preterm infant than in the 
term infant, and those of the term infant less mature than those seen in the child and adult. 
Although fetuses in utero are able to swallow amniotic fluid from as early as 20 weeks of gestation, 
the sucking mechanism does not appear until 32 to 34 weeks gestation (16).  Gastric emptying of 
swallowed amniotic fluid into the intestine may be demonstrated in the human fetus at 30 weeks’ 
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gestation (17).  Between 28 and 38 weeks gestational age, the gastric antral contraction amplitude 
increases from 10 to 40 mmHg.  Emptying half-time doubles when newborns of 28-34 weeks are 
compared with full-term neonates indipendent of feeding.  
Contractions may occur singly, but occasionally phasic contractions may be sustained for 3 
to 5 minutes.  However preterm infants had fewer antral clusters coordinated with duodenal clusters 
than term infants (18). 
 
Small intestinal motility 
Although complete interdigestive cycles can be observed occasionally in term infants, they are very 
rarely seen in preterm infants.  Approximately 75% of the recording obtained from neonates are 
occupied by a motor pattern that is not tipically seen in adults: the nonpropagating cluster of 
contraction.  This pattern consists of bursts of 11 to 13/minute contractions last 1 to 3 minutes and 
do not migraite from the proximal gut to the distal gut (1).  With increasing gestational age, motor 
contractions become more organized, the duration of a single cluster become longer as is the 
duration of the motor quiescence separating clusters.  As a result this dominant pattern still occupy 
75% of the recordings of term infants but clusters are longer (3-4 minutes) and their occurrence is 
lower (6 to 8 times per minute).  The migrating motor complexes (MMC) appears between 32 to 35 
weeks postconception, as the overall occurrence of clusters decreases (19).  Some of these MMC 
are poorly organized with slower propagation velocities.  
In spite of an apparent immaturity of fasting activity, intestinal motor activity pattern in 
preterm and term infants change in response to feeding.  However the appearance of fed pattern is 
different at different gestational ages.  Term neonates shown a fed pattern similar to that seen in 
adults. In contrats to term infants, only 25% of preterms infants display a mature type of fed pattern 
while about 75% display a prompt cessation of motor contraction after feeding.  This pattern, 
associated with a delay in gastric emptying, is probably due to immaturity of vagal regulation.  
  18 
 
Feeding and development of motility 
There is convincing evidence that acute response of motor activity and peptide release are present 
with the first enteral feeding and that the provision of early enteral feedings facilitates functional maturation 
of the human intestine.  Babies can respond to enteral nutrition  as early as 25 weeks of gestational age (20).  
These evidences suggest that the small intestinal fed response is a more primitive form of motor activity than 
is the fasting motor activity.  For this reason the practice of delaying the use of enteral nutrition in the very 
low birth weight infant may not coincide with preterm intestinal physiology of  motor function. 
Several studies have shown that gut function and  subsequent milk tolerance is improved by 
trophic feeding.  Trophic feeding (minimal enteral feeding, gut priming, early hypocaloric feeding) 
is a practice that involves feeding small volumes of milk, nutritionally insignificant but beneficial to 
the developing gut.  Recent studies have reported that this practice accelerates the whole gut transit 
probably by enhancing the MMC.  The mechanism by which trophic feeding exerts its influence is 
unknown.  It is responsible for surges in the plasma concentration of several enteric hormones and 
peptides which alter gut motility (motilin, gastrin, neurotensin and peptide YY) and may cause 
stimulation of the ENS (21). 
The manner in wich babies are fed may also trigger differences in motor responses. 
Maturation of motor function requires that nutrient be fed to the neonates because feeding sterile 
water does not produce this effect (22).  Preterm infants fed by a 2 hour infusion display a brisk 
increase in motor contraction that is associated with a faster gastric emptying  compared with 
infants fed by 15-minutes bolus.  Feedings volumes that provide as little as 10% of daily fluid 
intake significantly induce the premature appearance of MMC as those that provide 30% or 100% 
(23).  
In conclusion  minimal feeding volumes can be used to trigger maturation of motor function  
avoiding at the same time the risk of enterocolitis that larger feeding volumes incute.  However, 
  19 
since cluster rapresents 60-75% of the motor activity in the term infants who have complete 
interdigestive cycle, the motor activity in these  neonates is still very dissimilar from that seen in the 
adult, suggesting that further changes occur throughout infancy. 
 
Colonic motility 
The role of trigger that the enteral nutrition occupies in the development of gastrointestinal 
function rapresents a major factor in the ontogeny of colonIC motility, too.  It seems that colonic 
motilty matures late in gestation and has different characteristics in the infants compared to the 
older children and adults.  
Meconium can be found in the fetal rectum after the 21 week of gestation and as much as 10 
to 20% of total amniotic fluid proteins derive from the fetal gut.  These data suggest that defecation 
in utero occurs physiologically during the late stages of pregnancy and it is now believed that the 
detection of meconium in the amniotic fluid might reflect impaired clearance of meconium rather 
than excessive or inappropriate elimination in the amniotic fluid . 
The correlation among early enteral feeding, passage of the first stooling, stool frequency 
and consistency had been largely discussed in pediatric literature. 
Coordinated sucking and swallowing, required for the independent utilisation of milk feeds, 
is not achived until 32-34 weeks’ gestation, after which time most preterm infants are capable of 
taking feeds by mounth.  This gestational age coincides with a significant increase in defecation rate 
and a surge in circulating concentrations of intestinal regulatory polypeptides (gastrin, motilin and 
neurotensin) in response to milk feeds.  
In newborn infants, who do not have voluntary control, evacuation probably occurs in 
response to an increasing volume of stool in the rectum.  In a large study observing bowel habits in 
844 preterm infants, a direct relation between the volume of milk ingested and stool frequency 
throughout the first eight weeks after birth was reported (24).  Infants who received no milk had a 
modal frequency of one stool each day whereas those receving greater than 150 ml/Kg/day passed 
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between three and four stools each day.  Infants receiving human milk had consistently higher 
defecation rate, and passed softer stools, than those receiving formula milk, irrespective of 
gestational age and feed volume.  The finding of a modal frequency of one stool each day in the 
unfed neonate suggests that there is an intrinsic pattern of large bowel motor activity present as 
early as 25 weeks’ gestation.  This daily passage of stool may perform the “housekeeping” function 
of clearing the colon of intestinal secretions and other unwanted material.  Probably, milk feeds 
override the intrinsic fasting motor activity of the colon and induce regular defecation at a 
frequency determinated directly by the volume of the products of digestion that reach the rectum: 
the more feeds, the more stools. 
 In full term and preterm infants, the peak stool frequency occurs during the first week after 
birth, after wich there is a decrese, in spite of increasing milk intake, indicating a maturation of the 
water conserving ability of the gut.  It is not known, however, whether this is due to the increasing 
efficiency of small inetstinal absorption or colonic water retention. 
Term newborn infants average four bowel movements/day for the first week of life.  The 
frequency of defecation decreases with age, so that 85% of children 1-4 years old defecate once or 
twice daily.  High amplitude (> 60 mmHg) propagating contractions (HAPCs) are the manometric 
correlate of the radiologic “mass movements” and are responsible for the rapid movement of feces 
in the aboard direction.  The presence of HAPCs together with an increase in colonic motility after a 
meal, are markers for neuromuscolar integrity of the colon in toddlers and children (17).  HAPCs 
decrease in frequency from several per hour after a meal in awake toddlers to just a few per day in 
adults (25).  The gastrocolonic response seems also more prominent in younger compared to older 
children.  Nevertheless the colon in toddlers seems to have fewer tonic and phasic non-HAPCs 
contractions compared to the colon of older subjects.  Informations about age related changes in 
colonic tone are absent. 
The ongoing developmental maturation of bowel function results in intestinal hypomotility 
with consequent  postponement of meconium passage.  The first studies to measure intestinal transit 
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in humans used amniography; aboral transport of contrast did not occur in the intestinal tract of 
fetuses younger than 30 weeks gestation.  Using amniography, Mc Lain observed that gastro-
intestinal motility increased with advancement of gestational age; progression of contrast material 
from the oral cavity to the colon took as long as 9 hours at 32 weeks of gestational age, but only 
half of that time by the time of labour (16).  Intestinal transit is approximately three times slower in 
preterm infants compared with that seen in the adults. 
It has been noted previously that more than 90% of full term infants and 100% of post-term 
infants passed their meconium within the 24 hous.  There has been agreement on the general 
principle that defecation should be avoided in utero and that lack of defecation after birth is a sign 
of disease.  In fact it is generally believed that the passage of meconium into the amniotic fluid is an 
indicator of fetal distress.  Nevertheless meconium-stained amniotic fluid is found up to 30% of all 
deliveries, and no cause of fetal distress is found in up to 25% of all occurrences of meconium 
stained amniotic fluid (26).  
In premature infants with a birth weight of 1000 g or less the first stool is passed at a median 
age of 3 days and 90% have their first stool by 12 days after birth (27).  Meetze et al (28) found a 
median age of 43 hours for passage of the first stool in 47 patients with birth weights 1259 g or less. 
One forth of these infants had not passed stool by 10 days of age.  Weaver and Lucas (24) reported 
32% delay in passing meconium greater than 48hours with an inverse relation between gestational 
age and the time of first bowel action.  Extreme prematurity and delayed enteral feeding were 
significantly associated with delayed passage of the first stool in more than one study (29-30). 
Therefore a delayed passage of meconium and constipation could be induced by a delayed 
itestinal transit in particular evident at the level of the colonic segments.  Naturally, a normal 
development of the upper gastrointestinal tract (stomach; small intestine) is essential to warrant a 
correct maturation  of the colonic motility, too. 
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In conclusion, we have underlined as the ontogenesis of gastrointestinal motor activity is 
influenced by several factors such as the smooth muscle activity, the CNS, the ENS and the 
neurohumoral system.  
We have also seen that early enteral feeding occupies a main role in the promotion of development 
of small intestinal functions and colonic motility.  
Further understanding about the timing of specific motor patterns in humans and their 
control mechanisms may allow neonatologists to rich the optimal feeding strategies to induce the 
better gastrointestinal function and  to obtain the optimal feeding tolerance. 
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ABSTRACT 
The prevalence and natural history of gastro-esophageal reflux (GER) in infants have been 
poorly documented. Aim: To evaluate the prevalence and natural history of infant regurgitation in 
Italian children during the first two years of life. Methods: A detailed questionnaire prepared on the 
basis of the Rome II criteria was completed by fifty-nine primary care pediatricians to assess infant 
regurgitation on consecutive patients seen in their office over a 3-month period. A total of 2642 
patients aged zero to 12 months were prospectively enrolled during this 3-month period. Follow-up 
was performed at 6, 12, 18 and 24 months of age. Results: A total of 313 children (12 %; 147 girls) 
received the diagnosis of infant regurgitation. Vomiting was also present in 34/313 patients (10.9%). 
Their score for the Infant Gastro-esophageal Reflux Questionnaire (I-GERQ) was 8.51 ± 4.75 (mean 
± SD). Follow-up visits were carried out to the end in 210/313 subjects. Regurgitation had 
disappeared in 56/210 infants (27%) by the first 6 months of age, in 128 (61 %) by the first 12 
months, in 23 (11 %) at 18 months and in 3 patients (1 %) by the first 24 months. At follow-up 1/210 
(0.5 %) patients had developed a GER-disease with esophagitis endoscopically and histologically 
proven; another patient received a diagnosis of cow milk protein intolerance. The I-GERQ score 
reached 0 after 8.2±3.9 months in breast fed infants (89/210), and after 9.6±4.1 months in artificially 
fed infants (p = 0.03). 
Conclusion: We have found that 12% of Italian infants satisfied the Rome II criteria for infant 
regurgitation. 88% of 210/313 who had completed a 24 month follow-up period had improved at the 
age of 12 months. Only one patient later turned out to have GER disease. Breast milk was associated 
to a shorter time necessary to reach a complete normalization of the I-GERQ. 
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INTRODUCTION 
Gastroesophageal reflux (GER) is a common reason for pediatric visits and referrals to 
pediatric gastroenterologists. Regurgitation occurs more than once a day in 67% of healthy 4-
month-old infants. Many parents believe regurgitation is abnormal; 24% bring this symptom to their 
clinician’s attention during their infant’s sixth month (1). Although the symptoms of GER are 
common and often treated in a primary care setting, the natural history of GER in childhood has 
been poorly documented.  Most studies have been cross-sectional, retrospective, or biased toward 
hospital-based populations. Only two previous studies have prospectively examined infants in the 
community to determine the outcome of infant spilling (2-4). Nelson et  al. (1) reported that at least 
one episode of regurgitation a day was present in half of  zero-to-three-month-old infants. Peak 
reported regurgitation was 67% at 4 months, and the prevalence of  symptoms decreased 
dramatically from 61% to 21% between 6 and 7 months of age. By the age of 10 -12 months, 5% of  
study subjects were still spilling. This study was limited because in its selection process, the authors 
cross-sectionally chose children who were younger than 13 months, and prospectively followed 
only children who were 6 months or older at enrolment. Furthermore, they followed  patients only 
once, 1 year later. Martin et al.(5) longitudinally evaluated the natural history of infant spilling 
during the first 2 years of life and determined the relationship between infant spilling and GER 
symptoms at 9 years of age. A total of 41% of infants were spilling most feed between 3 and 4 
months of age and the percentage gradually declined, according to age, falling to <5% between 13 -
14 months; symptoms disappeared by 19 months of age. However, all these studies lack of a 
standard definition of GER.  
 The Rome II criteria for functional gastrointestinal disorder in children provided a standard 
definition for the diagnosis of infant GER for the first time (6). These criteria represent a valid 
instrument to assist the physician in a positive diagnosis of GER – thus allowing them to avoid 
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many invasive batteries of tests - and to assist the researcher in order to use definitions which are as 
standardized as possible.  
Our objective was to perform a prospective survey in the general Italian pediatric population 
during the first two years of life in order to determine the prevalence and natural history of GER, as 
defined by the Rome II criteria. 
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METHODS 
 In Italy all children from birth to 14 years of age are enrolled in the National Health Service 
(NHS).  NHS pediatricians have under their care  approximately 800 children each, who are 
distributed evenly throughout  the country  to cover the health needs of the entire Italian pediatric 
population.  Initially seventy-five primary care pediatricians, from north-central and southern Italy, 
were selected. Those pediatricians were chosen from communities of all sizes, throughout the 
territory, by random selection of evenly numbered members provided from the membership list of 
the regional pediatric society.  Subsequently, regional coordinators of the study within each territory 
presented the aim, outline and questionnaires of the study to the selected pediatricians. The survey 
was conducted by 59 pediatricians who agreed to participate in the study.  
  From April 1 to June 30, 2004, each participating pediatrician was asked to record the 
number of infants examined per day in their office for acute, chronic care or routine follow-up 
evaluation, and to complete for each consecutive patient a detailed questionnaire to assess infant 
regurgitation according to the Rome II Criteria (6) (Table 1). Evidence of metabolic, 
gastrointestinal or central nervous system diseases, chronic debilitating diseases, neurological 
abnormalities, previous surgery of the gastrointestinal tract, use of acidsuppressive therapy (H2-
antagonists, proton pump inhibitors) were considered exclusion criteria. In addition, infants with 
hematemesis, anemia, aspiration, apnea, failure to thrive, abnormal posturing and feeding or 
swallowing difficulties, were excluded from the study.  
 Each child with a diagnosis of infant regurgitation according to the Rome II criteria was then 
reexamined by the same pediatrician with an interval of 2 months, until the age of 24 months, to 
determine whether there had been a resolution/worsening of symptoms or a change in the diagnosis 
(i.e. GERD, cow milk protein intolerance). After the diagnosis, additional investigation and 
treatment were left to the discretion of the primary care pediatrician. However, meetings were held 
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before, during, and at the end of the study period to standardize the protocol and the 
diagnostic/therapeutic management of patients, according to the current practice (7).  Treatment 
options included reassurance, formula thickening with dry rice cereal and postural manipulations. 
The use of prokinetics (domperidon), alginate and/or aluminium hydroxide was allowed on demand 
as rescue medication. 
A validated score (2) (I-GERQ GERD, modified) was completed at enrolment and during 
the follow-up visits. The I-GERQ GERD modified, consisted of 14 items regarding characteristics 
of regurgitation (frequency and volume), feeding refusal, weight gain, irritability and  crying (daily 
frequency and correlation with meal), hiccups, arching back, respiratory symptoms and posture, and 
assigned points for positive response, for a maximum possible score of  31.  All patients received a 
standard history and a physical examination; in particular the information collected were 
demographics, symptoms (e.g. regurgitation, vomiting, weight deficit, pain suggestive of 
esophagitis, respiratory symptoms), possible provocative factors (e.g. smoke exposure, prematurity, 
history of atopy), feeding (breast milk or formula), familiarity with gastrointestinal symptoms. 
The study protocol was presented and approved by the Italian Society for Pediatric 
Gastroenterology, Hepatology and Nutrition (SIGENP). Informed consent for participating in the 
study was obtained from parents of all patients, and the experimental design was approved by the 
Independent Ethics Committee of University of Naples, Federico II. 
 
Statistical analysis 
Continuous data (age, weight, I-GERQ score) were compared, between initial and final values, 
using t-tests, unpaired or paired as appropriate. Cross-tabulations were evaluated by using the χ2 
method. Statistical significance was predetermined as p < 0.05. Percentages were rounded to the 
nearest whole numbers 
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RESULTS 
 Fifty-nine out of 75 randomly selected pediatricians agreed to collaborate, with a 
participation rate of 78%. A total of 2642 infants were prospectively enrolled during the 3-month 
recruitment period. Their age range was from 1 to 12 months, with a mean ± SD of 5.6 ± 3.6 
months . The socioeconomic status of all patients ranged from lower-middle class to upper-middle 
class. A total of 313 children (12 %) received the diagnosis of infant regurgitation according to the 
Rome II criteria. The mean age of affected infants was 3.8 ± 2.7 months, and the male:female ratio 
was 166:147. The mean value of the I-GERQ score at the study entry was 8.51 ± 4.75; it was > 7 in 
151/313 (48%). Children with I-GERQ score < 7 did not show significant differences from children 
with a score ≥ 7 in terms of nutritional status, being their BMI z-scores 0.3 ± 1.23 and  0.21 ± 1.19 
(p = 0.2) respectively . Vomiting was also present in 34/313 patients (10.9%), whose initial score 
was significantly different from the score of children without vomiting (I-GERQ score mean ± SD: 
11.6 ± 3.7 vs 7.6 ± 4.5, respectively; p = 0.0003). These scores continued to be significantly 
different at the moment of the first follow-up visit (2 months later), being 6.8 ± 4.3 in children with 
vomiting and 3.8 ± 3.4 in children without vomiting (p = 0.0003). Such a difference was lost later 
on. No significant difference was found, during the first follow-up visit, between children with or 
without vomiting in terms of body-weight gain (mean ± SD: gr 1174 ± 437 and 1287 ± 614, 
respectively; p = 0.3). As illustrated in Fig. 1, most children with GER are in their first 150 days of 
life. Two hundred and thirty-three (74 %) out of 313 children were 1 - 5 months old and their score 
at inclusion in the study protocol (8.8 ± 4.7) was significantly higher compared to children older 
than 5 months (No: 80; age: 6 - 12 months; I-GERQ: 7.5 ± 4.8; p = 0.04). Such a difference 
remained persistently significant also after 4 and 6 months (Fig. 2). Considering the potential risk 
factors for GERD, no significant difference was found at enrolment between the I-GERQ score of 
children who were preterm at birth and that of children who were at term (p= 0.08) (Tab. 2). A 
significant difference (p= 0.005) was present between scores of children born from atopic parents 
and children born from non-atopic parents (Tab. 2). Such a difference was lost after a 6-months 
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period (I-GERQ score: 5.3 ± 4.5 and 5.0 ± 3.8 respectively; p = 0.2) and it had no impact on the 
time necessary to reach a complete normalization of the I-GERQ. No significant difference was 
found between scores of children born from smoking mothers and children born from non-smoking 
mothers (p = 0.09) (Tab. 2). Since 103 patients were lost at follow-up visits, a complete data 
collection of the follow-up evaluation was only available for 210 children out of the original 313 
patients (67%). Regurgitation had disappeared in 56/210 infants (27%) by the first 6 months of age, 
in 128 (61%) by the first 12 months, in 23 (11%) by the first 18 months  and in 3 patients (1 %) at 
24 months (Fig. 3).They had been treated with reassurance in 72 % of cases (I-GERQ score: 8.1 ± 
4.7), formula thickening in 6 % (I-GERQ score: 8.5 ± 4.2), antacids in 9 % (I-GERQ score: 10.8 ± 
4.8), prokinetics in 3 % (I-GERQ score: 6.3 ± 2.9). At follow-up visits 1/210 (0.5 %) patients had 
developed GER disease with esophagitis endoscopically and histologically proven. Another patient 
received a diagnosis of cow milk protein intolerance.  
The I-GERQ score reached 0 after 8.2 ± 3.9 months in breast fed infants (112/265), and after  
9.6 ± 4.1 months in artificially fed ones (p = 0.03). 
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DISCUSSION 
Regurgitation in infants is among the most common causes for physician consultation 
worldwide, but the heterogeneity of its diagnostic criteria and the lack of a reliable and valid non-
invasive instrument to evaluate progression and remission of GER over time has restricted any 
possibility to evaluate its exact prevalence and natural history. In other words, “infant regurgitation” 
has not been a standardized diagnostic definition before the Rome criteria for functional disorders in 
children had been developed and published. That is why epidemiologic studies regarding 
regurgitation in infancy might not have been appropriate in the past - in fact data from literature 
reported a wide variety of percentages (8), sometimes accounting for serious manifestations of 
complicated GER, sometimes limiting the observations to children with one regurgitation episode 
per day (1). In the present study, for the first time, the Rome II criteria (7) have been used to 
evaluate the  prevalence of regurgitation in children who had healthy baby check-up during their 
first year of life.
 
Moreover, since evaluating an infant with regurgitation is often misleading without 
an objective instrument able to differentiate clinically meaningful change from clinically 
insignificant change, the I-GERQ score was chosen as an objective evaluative tool to obtain 
prospective longitudinal information regarding the natural history of infant regurgitation during the 
first two years of life. 
 
Infant regurgitation was diagnosed in 12% of the 2642 infants recruited for 
the study protocol, which is a prevalence lower than previously observed in other studies. Nelson et 
al reported that at least one episode of regurgitation a day was found in a half of 0- to 3-month-olds 
and peak reported regurgitation was 67% at 4 months (1). In a recent prospective longitudinal study 
of the natural history of spilling in children followed from birth, it was shown that spilling reaches a 
peak of 41% among infants between 3 and 4 months old (5). Since we doubt we have overlooked  
many infants with regurgitation in our study – due to the fact that Italian parents are encouraged by 
the NHS to see pediatricians for the smallest problem – a possible explanation accounting for our 
lower prevalence could be that we have made use of a stricter definition of infant regurgitation 
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based on both frequency (2 or more episodes per day) and duration (3 or more weeks), according to 
the Rome II criteria. None of our infants had any GER-related complications, such as aspiration, 
apnea, abnormal posturing, and there was no significant difference in BMI z-scores between 
children with a score  higher or lower than 7, which is the value usually indicated as the threshold 
limit over which the presence of GERD is a possible  risk. Considering that a value higher than 7 
was observed in almost a half of our infants with regurgitation, these data might also suggest that an 
I-GERQ score higher than 7  is consistent with functional GER, with no reduction in growth 
velocity and any other associated alarm symptoms for GERD.  In addition to regurgitation, 
vomiting was also observed in 10.9% of cases and did not seem to have any effects on the patient’s 
nutrition, thus suggesting that – again – functional GER might be accompanied by symptoms 
currently considered indicative  of GER-related complications. Children with or without vomiting 
showed significantly different I-GERQ score values, which were obviously higher in the former 
group; this difference was still present at their first follow-up visit (2 months later) and was lost 
later on. The data show that infant regurgitation is mainly prevalent in the first 5 months of life and 
the younger the infant is, the higher the I-GERQ score becomes. Infants who used to regurgitate 
between 6 and 12 months of age were no longer doing so a year later. On the basis of these data, 
and according to Nelson et al.(1), pediatricians can predict that when regurgitation lasts for over 6 
months of age it usually resolves over the following year. Considering the possible risk factors for 
GERD, we did not find any differences, in terms of I-GERQ score, between preterm- and term-
infants at enrolment in the study protocol, but these data are limited by the exiguous number of 
preterm-infants (only 27) in our patient population. Infants born from atopic parents showed 
significantly higher I-GERQ score values, which did not seem to have an impact on the time 
necessary to reach a complete normalization of the scores. This overt discrepancy might be related 
to the consciousness of their  parents to be atopic, which indicates a higher sensitivity towards any 
atopy-related symptom. In other words, atopic parents could view infant regurgitation as a problem 
more often than non-atopic parents. ETS (= exposure to environmental tobacco smoke) has been 
  55 
reported to induce lower esophageal sphincter relaxation (9, 10) and it has been shown a strong 
correlation between esophageal pH and ETS exposure in infants exposed to apparent life-
threatening events (11). Passive smoking has also been proposed as a risk factor for esophagitis in 
children (12). However, our study, in accordance with Martin et al.(5), does not indicate a clear 
relationship between maternal smoking and ETS in general, or infant regurgitation, neither in terms 
of prevalence, nor in terms of duration of the symptoms. Furthermore, we compared the frequency 
of regurgitation in infants receiving breast milk - seen as a possible protective factor from GERD - 
and in those receiving infant formula and, despite data from literature (5, 2, 13), we observed no 
significant difference in the prevalence of regurgitation, but a significant difference in terms of the 
time needed to reach a complete normalization of I-GERQ. These data indicate that breastfed 
infants stop regurgitating earlier than formula-fed ones. Although a complete data collection 
regarding the 24-month longitudinal follow-up was only available in 210 out of the original 313 
patients, we observed that the prevalence of infant regurgitation decreased markedly at 12 months 
of age, by which time the symptoms had disappeared in 88% of cases, and  no children displayed 
regurgitation at 24 months. Treatment was left to the discretion of the primary care pediatrician and 
consisted in reassuring about the physiologic nature of the symptoms and educating parents 
(frequent small feeds, postprandial burping, correct positioning), which were sufficient measures in 
72% of cases. The remaining infants were treated with formula thickening in 6% of cases, antacids 
in 9% and prokinetics in 3%. It is noteworthy that infants receiving antacid medication have been 
observed to show the highest I-GERQ score at inclusion. Only one infant was finally diagnosed as 
having cow milk protein intolerance – thus suggesting this is a rare condition - even though it is 
considered prudent to recommend a trial of hypoallergenic formula in the medical treatment of an 
infant with reflux (7). Only one patient received the diagnosis of GERD, with esophagitis 
endoscopically and histologically proven.  
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To conclude, infant regurgitation according to the Rome II diagnostic criteria is a common disorder, 
but less frequent than one might think in the past. In most cases its natural history is resolution 
within the first 18 months of life, and its treatment should be decided on the basis of the facts 
exposed in this study. Children older than 18 months who continue to regurgitate regularly should 
prudently receive additional evaluation. Cow milk protein intolerance and esophagitis should be 
considered infrequent conditions among children with infant regurgitation. Since there have been no 
changes from the Rome II to the Rome III criteria for the diagnosis of infant regurgitation (14), 
these data should be considered also in the light of the more recent diagnostic criteria for functional 
disorders. 
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FIGURE LEGENDS 
 
Fig. 1: I-GERQ score vs Age. Children with GER are mostly gathered in the first 150 days of age. 
 
Fig. 2: Age at recruitment vs I-GERQ score. I-GERQ score at inclusion of children 1 - 5 months old 
was significantly higher compared to children older than 5 months. Such a difference remained 
persistently significant also after 4 and 6 months. 
 
Fig. 3: 24 months follow up in 210 children with regurgitation. Regurgitation disappeared in 56/210 
infants (27%) by the first 6 months of age, in 128 (61%) by the first 12 months, in 23 (11%) by the 
first 18 months  and in 3 patients (1 %) at 24 months. 
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Table 1. Diagnostic criteria of Infant Regurgitation according to the Rome II classification (Gut  
 1999;45(SII):II60-II68). 
 
 
• Regurgitation 2 or more times per day for 3 or more weeks; 
• There is no retching, hematemesis, aspiration, apnea, failure to thrive, or abnormal 
posturing; 
• The infant must be 1-12 months of age and otherwise healthy; 
• There is no evidence of metabolic, gastrointestinal, or central nervous system disease to 
explain the symptom. 
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Tab. 2 – Risk factors for GERD 
Risk Factors Number of children I-GERQ score p 
Preterm children 27 9.51 ± 4.8 
At term children 286 8.7 ± 7.9 
 
0.08 
Atopic parents 77 9.8 ± 5.6 
Non atopic parents 227 8.0 ± 4.4 
 
0.005 
Smoking mothers 38 9.0 ± 4.9 
Non-smoking mothers 275 8.5 ± 4.7 
 
0.09 
 
Data are expressed in mean ± SD 
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I-GERQ score versus Age
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Age at recruitment vs I-GERQ score
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24 months follow up in 210 children with regurgitation
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ABSTRACT 
 
Background & Aims: Patients with constipation frequently complain of dyspeptic symptoms that 
may be explained by reflex inhibition of upper gastrointestinal motor activity by colonic stimuli. 
We sought to evaluate: 1) the prevalence of functional constipation (FC) and gastric emptying 
characteristics in children with functional dyspepsia (FD), and 2) the efficacy of osmotic laxatives 
on constipation, dyspeptic symptoms and gastric motility.  Methods:  We recruited 42 children 
(M/F 22/20; mean age 80.5 months) affected by FD (Rome II criteria). All subjects underwent 
ultrasonographic measurement of the  total gastric emptying time (TGEt) at baseline (T0) and after 
three months (T3). Children’s bowel habits and the dyspeptic symptomatic score were evaluated at 
entry and after one (T1), two (T2) and three months (T3).  Constipated patients were treated with 
osmotic laxatives for three months.  Dyspeptic children without constipation represented the 
comparison group. Results:  FC was present in 28/42 (66.6%) patients.  Constipated dyspeptic 
children had significantly more prolonged TGEt than subjects without constipation (median value 
(IQR) 180 (50) vs 150 (28) minutes, respectively; p=0.004). Patients on osmotic laxatives had a 
significant decrease in TGEt at three months (p<0.001). The median dyspeptic symptomatic score 
as well as the number and consistency of evacuations per week significantly improved at T1 in 
comparison to T0 and even more at T2 and T3 (p<0.001, for each). Conclusion:  In our study group, 
the majority of children with FD were affected by FC associated with delayed gastric emptying.  
Normalization of bowel habit may improve  gastric emptying as well as dyspeptic symptoms. 
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INTRODUCTION 
Dyspeptic symptoms including fullness, bloating, early satiety, heartburn, nausea, intermittent 
vomiting, and upper abdominal pain may be commonly seen in patients with constipation (1,2).  
Borowitz et al (3) reported that 34 children rapidly and completely resolved chronic upper 
gastrointestinal (GI) symptoms when their constipation was treated. 
Some of these upper GI symptoms related to delayed gastric emptying may be explained by reflex 
inhibition of upper GI motor activity by colonic stimuli (4-8).  Studies in experimental animals 
showed that balloon distension of the colon caused rapid inhibition of gastric and intestinal 
contractions and tone.  When the balloon was deflated, there was an immediate rebound increase in 
tonus and motility which suggests a nervous component (6,7).  It was also shown that in adults, the 
intermittent distension of the rectum, at a level below that which caused any discomfort, delayed the 
passage of a solid meal through both the stomach and the small intestine (8).  In addition, it has 
been reported that voluntary suppression of defecation delayed gastric emptying in healthy subjects 
(1).  Therefore, this “cologastric brake” may be involved in the pathogenesis of upper abdominal 
symptoms in constipated patients. 
Although gastric emptying was studied in a variety of childhood diseases (9), it was poorly 
investigated in constipated children.  Ultrasonographic evaluation of gastric emptying was shown to 
be a reliable method to assess gastric emptying disorders in children (10-13).  However, widespread 
clinical application of ultrasonography has been limited by paucity of data from studies in disease 
states (14). 
The aims of our study were to evaluate: 1) the prevalence of functional constipation (FC) and the 
gastric emptying characteristics in children affected by functional dyspepsia (FD); 2) the efficacy of 
osmotic laxatives not only on constipation, but also on dyspeptic symptoms as well as on gastric 
motility. 
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SUBJECTS AND METHODS 
Ninety-nine   patients were consecutively recruited from children with complaints of upper 
GI symptoms referred to our tertiary academic gastroenterology outpatient clinic. Upper GI 
endoscopy was performed when indicated. Recruitment took place from June 2005 to July 2006. 
Forty two of them (22 males; mean age 80.5 months; range 48-199) were affected by FD according 
to the Rome II criteria (Table 1)(15) and represented our study group. Apart from age and gender, 
subject demographics were not included because they were not relevant to the evaluation of the 
study’s outcomes. The Questionnaire on Paediatric Gastrointestinal Symptoms (QPGS) was used to 
make the diagnosis of FD at entry and a diagnosis of FC (Table 1) -section C (bowel movements)- 
in the group of dyspeptic patients (15,16). This questionnaire is a validated instrument for 
qualitative and quantitative assessment of constipation according to the paediatric Rome II criteria. 
We didn't choose Rome III criteria for diagnosis of FC and FD because they had not yet been 
published when the study protocol started. 
Children with organic causes of defecation disorders, including Hirschsprung’s disease, 
spina bifida occulta, hypothyroidism, chronic intestinal pseudo-obstruction, previous surgery of the 
gastrointestinal tract, or with systemic disease, central nervous system disease and chronic severe 
illness, were excluded from the study.  In addition, children who were taking any form of 
constipation treatment were excluded and all drugs directly and indirectly affecting  GI motility, 
including acid suppressive therapy, were discontinued at least two weeks prior to the study.  
A full medical history together with a complete physical examination were obtained at entry 
(T0). Constipated patients were treated with oral lactulose at the standard dose of  1 mg/Kg/day, 
once daily, for a period of three months. Dyspeptic children without constipation did not receive 
any treatment and were used as comparison group. No patient underwent  acid suppressive therapy 
during the study period. The use of alginate and/or aluminium hydroxide was allowed as rescue 
medication, on demand. 
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Dyspeptic symptoms  and bowel habit were evaluated with validated questionnaires at 
enrolment (T0); and after one (T1), two (T2) and three (T3) months of follow-up. All subjects 
underwent measurement of the  total gastric emptying time (TGEt) performed by real time 
ultrasonography of the antral area at entry (T0) and after three months (T3). 
Informed consent for participation in this study was obtained from parents of all patients, 
and the experimental design was approved by the Independent Ethics Committee of University of 
Naples, Federico II 
ASSESSMENT OF SYMPTOMS 
Information concerning dyspepsia and constipation questionnaires and diaries were obtained 
by the parents of the children aged 0-9 years and by the children themselves aged 10-17 years. 
Dyspepsia  
A standardized questionnaire was used to assess the presence of epigastric pain, heartburn,  
nausea, early satiety, vomiting and bloating (17). Caregivers were also asked to keep a weekly 
diary of symptoms. The dyspepsia questionnaire was always administered by the same 
investigator during the clinic visits at entry (T0), at one (T1) two (T2) and three months (T3) of 
follow-up. Symptoms were scored numerically for frequency and severity. Frequency was scored 
as follows: 0_ absent, 1 _ 1 day per week, 2 _ several times per week. Severity was scored as 
follows: 0 _ absent, 1 _ present but not interfering with daily activities, 2_present and interfering 
with daily activities. A score for each symptom was calculated by multiplying the severity grade 
by the frequency grade, with a possible range for each score of 0 to 4. The total symptom score 
(TSS) (range 0 to 24) was obtained by adding up the scores for each symptom and was 
calculated for each patient. 
Constipation 
The defecatory pattern was established for the last week and prospectively for the first 3 
consecutive days from the scheduled visits (18). Questions were posed concerning the duration of 
constipation, frequency of bowel movements (BMs), presence of large diameter stools, presence of 
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stool withholding, of abdominal pain and/or of blood with BMs, presence of urinary incontinence, 
fecal incontinence (stains or soils underpants). Stool consistency was assessed as follows: hard like 
rock, pellets = 0, firm=1, soft= 2, loose =3 and watery = 4 (19). A weekly diary was kept from 
patients and parents to record the BMs characteristics during the three months of follow-up. At  1-
month, 2-months and 3-months visits the interim history was assessed and the stool diaries were 
collected and evaluated. 
 
Assessment of Gastric Emptying 
Measurement of gastric emptying time was performed by real time ultrasonography of the 
gastric antrum after ingestion of a mixed solid-liquid meal (Table 2) (10).  All subjects were 
examined using a 5-MHz linear probe applied to the epigastrium, with minimal abdominal 
compression.  Baseline scans were performed on an empty stomach, and follow-up measurements 
were performed at 30 and 60 minutes, and then at 15-minute intervals until emptying was complete.  
The gastric emptying time was calculated by measuring the cross-section of the gastric antrum at 
the sagittal plane passing through the superior mesenteric vein.  The antral cross-sectional area, 
elliptical in shape, was calculated by the following formula: 
  Area =  pi x longitudinal diameter x antero-posterior  diameter / 4 (11) 
and the stomach was considered empty when the cross-sectional area returned to baseline and 
persisted unchanged for at least 30 min.  The total gastric emptying time (TGEt) was calculated in 
relation to the start of the meal. 
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RESULTS 
Eighty of 99 consecutively recruited children complaining of upper GI symptoms underwent 
upper GI endoscopy. Ten patients  had no indication for endoscopy because of very mild symptoms, 
whereas nine caregivers  did not give their consent.  Forty-two children received a diagnosis of FD 
according to Rome II criteria. All 42 children with a diagnosis of FD underwent upper GI 
endoscopy. By endoscopy, thirty-five (83.3%) of them showed normal macroscopic finding; 7 
(16.6%) had H.pylori gastritis.  The following disorders were found in the remaining patients:  
mild-moderate peptic esophagitis in 21 (26.2%); hiatal hernia in 5 (6.2 %); H.pylori gastritis in 7 
(8.75%) and not H.pylori  related gastritis in 5 (6.2%).   
Because none of the dyspeptic children infected by H.pylori showed evidence of gastric or duodenal 
ulcer, no eradication therapy was performed. 
Functional constipation was present in 28 (66.6%) out of 42 dyspeptic patients. The TGEt at 
enrollment (T0) was significantly more prolonged in dyspeptic children with constipation than in 
subjects without constipation (median value, Interquartile range (IQR) 180 (50) vs 150 (28) 
minutes, respectively; p=0.004). Patients on lactulose had a significant decrease in the TGEt  after 
three months (T3) of constipation treatment  (p<0.001, compared with T0 (entry) (Figure 1). There 
was no significant change of the TGEt in the group of dyspeptic children without constipation 
during the follow-up period in comparison with baseline (Figure 1). 
The median (IQR) total symptomatic score in dyspeptic constipated children at entry (T0) 
was  9 (10), with values of  3 (8) at T1, of  1.5 (4) at T2, and of 0 (2) at T3.  The total dyspesia 
symptomatic score  significantly decreased from baseline (T0) at T1 (p<0.001 vs baseline). 
Moreover a significant reduction was observed for this symptomatic score between T1 and  T2 
(p=0.01)and between T2 and T3 (p=0.001) (Figure 2). No statistically significant difference was 
found in the group of dyspeptic children without constipation, regarding the total dyspepsia 
symptomatic score, during the three months of follow-up (T1, T2, T3) compared with T0 (p=0.880) 
(Figure 2).   
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The frequency of BMs per week improved significantly during the 3-month treatment period 
(T1, T2, T3) as compared with the initial evaluation (T0) (p<0.001), in the dyspeptic children with 
constipation;  while no significant change was observed in the group of dyspeptic children without 
constipation (Figure 3). Dyspeptic children with constipation showed a significant reduction of the 
stool consistency assessed by the constipation score after three months of lactulose treatment 
(median value (IQR) T0 1(1); T1 2(1); T2 2(1); T3 3(1); T0 vs T3 p<0.001). The constipation score 
remained unchanged during the 3-month follow-up period in the dyspeptic patients without 
constipation (median value (IQR) T0 2 (1); T1 2 (1); T2 2 (1); T3 2 (1); T0 vs T3 P=0.821). 
Among the presenting dyspeptic symptoms, epigastric pain was the most frequent (100%)  
followed by vomiting (82.1%) and bloating (71.4%), in the dyspeptic constipated patients. All these 
symptoms were improved (epigastric pain 32%; bloating 18%) or disappeared (vomiting), after 
three months of constipation treatment (T3).  
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DISCUSSION 
Studies in children and adults suggest that constipation is part of a generalized GI motor 
disorder in which proximal GI motility can also be impaired (1,3-5,8).  In our study 66.6% of 
patients with FD were affected by FC.  All of our constipated children with FD showed a 
significantly prolonged TGEt compared with dyspeptic subjects without constipation. 
 In healthy, unconstipated adults, intermittent rectal distension significantly retarded the 
emptying of the meal from the stomach and delayed small intestine transit (8). The delay in gastric 
emptying  was abolished if the subject was pretreated with ranitidine (an acid-suppressant). This 
suggests that the inhibition of gastric emptying by rectal distension may be mediated by an increase 
in meal stimulated gastric acid secretion, which may than slow emptying by interaction with 
duodenal receptors.  Coreman et al. (20) determined the effect of continuous isobaric rectal 
distension on gastric emptying time and oro-cecal transit in young, healthy females and found that 
while gastric emptying was inhibited, small bowel transit was not.  The voluntary suppression of 
defecation for more than three days significantly slowed gastric emptying in the same manner (1). 
The mechanism by which rectal distention inhibits gastric emptying remains speculative but 
probably involves both neural and humoral components (6-8). Colonic loading with faecal materials 
may activate a recto-gastric inhibitory reflex  altering the function of gastrointestinal tract regions 
proximal to the colon.  This “cologastric brake” may be involved in the pathogenesis of dyspeptic 
symptoms. In our study  dyspeptic patients affected by constipation reported a prolonged gastric 
emptying time with a more severe dyspepsia symptomatic score. In addition, the  improvement of  
the bowel habit during the 3-month constipation treatment was correlated to a significant decrease 
of the dyspepsia symptomatic score as well as of the gastric emptying time.   
Gastric emptying, gastric accommodation and visceral hypersensitivity abnormalities have 
been demonstrated in symptomatic adult patients affected by FD (21-23). However, there are 
conflicting data about an exact relationship between constipation and dyspepsia. Van der sijp et 
al.(5) reported that patients with severe idiopathic constipation have delayed gastric and small 
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bowel transit that may be related to upper GI symptoms. A significant correlation was shown 
between the reduction of postprandial fundus relaxation and the presence of daily upper GI 
symptoms in slow transit constipated patients (4). On the contrary, in a recent study the authors 
concluded that although motor abnormalities of both colon and proximal GI tract regions are 
present in patients with chronic constipation and dyspepsia, they do not appear to play a role in the 
genesis of different dyspeptic symptoms (2).  A number of reports have associated abnormalities in 
the GI transit in children with upper GI symptoms (24-27,3) but data on gastric motor activity and 
on the prevalence of specific dyspeptic symptoms among constipated patients are lacking.  In 
previous papers, delayed gastric emptying has been reported in up to 68% of pediatric dyspeptic 
patients (28-29). Chitkara et al. (27) demonstrated that symptoms such as bloating and abdominal 
pain in pediatric and adolescent patients affected by FD may be associated with abnormal gastric or 
small bowel transit measurements. Recently it has been reported that 100% of 34 children 
complaining of chronic upper GI symptoms such as recurrent vomiting, nausea, gastroesophageal 
symptoms, abdominal pain, and early satiety suffered from chronic unrecognized constipation. The 
authors reported a significant improvement of  the upper GI symptoms once constipation was 
adequately managed (3). Another study investigated 28 children with functional fecal retention  
(FFR) and chronic constipation and found that postprandial symptoms of nausea, poor appetite and 
early satiety had disappeared after treatment of constipation. In contrast to our results, they showed 
no significant change in gastric emptying time (30).  
Two aspects of our data need explanation: 1) In our study H.pylori gastritis was found in 7 
(8.75%) children affected by FD. These children were included into the study and did not receive 
any eradication treatment. 2) H.pylori gastritis in these children may have affected gastric motility. 
The current recommendation from the North American Society for Pediatric Gastroenterology, 
Hepatology and Nutrition (NASPGHAN) is that H. pylori infected children with non ulcer 
dyspepsia or recurrent abdominal pain, or both, do not require treatment (31). According to these 
guidelines, eradication treatment is recommended only for children who have a duodenal or gastric 
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ulcer identified at endoscopy and H.pylori documented by histopathology and in the rare child with 
lymphoma  or proven atrophic gastritis with intestinal metaplasia. About the finding of H.pylori-
associated gastritis, in the absence of peptic ulcer disease at endoscopy, the committee concluded 
that there is insufficient evidence to support either initiating or withholding eradication treatment. 
We chose not to treat the patients since there was no clear indications in the guidelines in use, and 
because the use of acid-suppressant (included in the eradication therapy) could interfere indirectly 
with gastric motility   
Although a correlation between slowing of gastric emptying and increased severity of H. 
Pylori gastritis has been reported in adults (32-34), there are no studies in children. Recently Friesen 
et al. (35) reported that chronic gastritis in children is not associated with abnormalities of gastric 
electrical rhythm or solid food gastric emptying.    
It is widely recognised that patients suffering from functional gastrointestinal disorders 
(FGIDs) may have symptoms of multiple disorders concurrently. In a recent study on a large series 
of  adult patients, a significant overlap was found between upper and lower gastrointestinal 
symptoms and a relationship between different categories of functional gastrointestinal disorders 
(FGIDs)(31).  Caplan et al (16) showed that among children 4-9 years old, the majority of overlaps 
with other FGIDs diagnosis according to Rome II criteria were observed for FD, FFR and irritable 
bowel syndrome, (IBS) while in children of 10-18 years, the diagnosis of FD overlapped with that 
of IBS (2.9%), FFR (2.9%), functional constipation (FC) (0.7%) and cyclic vomiting syndrome 
(1.4%). 
Our data confirm the presence of overlaps among different  functional gastrointestinal 
disorders. However, the limitations of our study include the absence of a control group and the lack 
of a validated method for measurement of gastric emptying time and dyspeptic symptoms..  
In our study group, the majority of dyspeptic patients resulted affected by FC with a delayed 
gastric emptying time. The resolution of dyspeptic symptoms and gastric abnormalities after 
constipation treatment and bowel habit normalization suggests that, in a specific subset of patients, 
  82 
dyspepsia may be induced by constipation. The enterogastric feedback activated by faecal stasis in 
the rectum should be considered among the possible mechanisms involved  in the pathogenesis of 
dyspepsia.  
The demonstration of significant overlap raises the question as to whether the functional 
gastrointestinal disorders should be considered multiple separate disorders or as a unique clinical 
entity with a common pathophysiology, common symptoms and also, when possible, a common 
treatment.  
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FIGURE LEGENDS 
 
Figure 1 : Total gastric emptying time evaluated at entry (T0) and after three months of follow-up 
(T3) in dyspeptic patients with functional constipation (FC yes) who received lactulose and in 
dyspeptic patients without functional constipation (FC no) who did not receive any treatment. 
 
Figure 2: Dyspepsia symptomatic score evaluated at entry (T0) and after one (T1), Two (T2) and 
three (T3) months of follow-up in dyspeptic patients with functional constipation (FC yes) who 
received lactulose and in dyspeptic patients without functional constipation (FC no) who did not 
receive any treatment. 
 
Figure 3: Number of bowel movements per week evaluated at entry (T0) and after one (T1), two 
(T2) and three (T3) months of follow-up in dyspeptic patients with functional constipation (FC yes) 
who received lactulose and in dyspeptic patients without functional constipation (FC no) who did 
not receive any treatment. 
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Table 1. Rome II functional dyspepsia and functional constipation diagnostic criteria (Rasquin-
Weber et al. Gut 1999; 45(S2):II60-II68) 
FUNCTIONAL CONSTIPATION 
In infant and preschool children, at least two weeks of: 
• Scybalous, pebble-like, hard stools for a majority of stools; or 
• Firm stools two or less times/week; and 
• There is no evidence of structural, endocrine, or metabolic disease. 
 
FUNCTIONAL DYSPEPSIA 
In children mature enough to provide an accurate pain history, at least 12 weeks, wich need not 
to be consecutive, within the preceeding 12 months of: 
• Persistent or recurrent pain or discomfort centered in the upper abdomen (above the 
umbilicus; and 
• No evidence (including at upper endoscopy) that organic disease is likely to explain the 
symptoms; and 
• No evidence that dyspepsia is exclusively relieved by defecation or associated with the 
onset of a change in stool frequency or stool form. 
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Table 2. Test meals for gastric emptying time administered in different age groups 
Age (years) Bread (g) Ham (g) Butter (g) Fruit juice (ml) 
3-6 70 25 4 100 
>6-9 80 30 7 125 
>9-12 90 30 7 125 
>12 100 40 8 125 
Bread, 290 kcal/100 g; ham, 370 kcal/100g; butter, 750 kcal/100 g; fruit juice, 56 kcal/100 ml 
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Table 3. Frequency of reported dyspeptic symptoms at enrollment (T0), at  one-month (T1) two- 
months (T2) and at three-months (T3) after constipation treatment started in the 28 constipated 
dyspeptic children. 
 
 
 
 
 
 
 
 
 
 
 T0 T1 T2 T3 
Patients who experienced symptoms, n (%) 28 (100) 19 (67.8) 16(57.1)  13(46.4) 
Frequency for each reported symptom, n (%) 
   Vomiting  
   Heartburn 
   Epigastric pain 
   Nausea  
   Early satiety 
   Bloating 
    
 
18(64.2) 
2(7.1) 
28(100) 
16(57.14) 
20(71.4) 
23(82.1) 
 
 4(21) 
2(10.5) 
10 (52.6) 
7 (36.8) 
5 (26.3) 
8 (41.1) 
 
4(25) 
1(6.2) 
4(25) 
5(31.2) 
3 (18.2) 
 4(25) 
 
 
3 (0) 
2 (0) 
0 (0)  
1 (2.2) 
0 (0) 
0 (0) 
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CHAPTER 3 
DIAGNOSIS  AND TREATMENT OF  THE MAIN PEDIATRIC GASTROINTESTINAL 
MOTILITY DISORDERS. 
  
-Staiano A, Boccia G, Miele E, Clouse RE. Segmental characteristics of oesophageal peristalsis 
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- Boccia G, Buonavolontà R., Coccorullo P, Manguso F, Fuiano L, Staiano A. Chronic Cough and 
Gastroesophageal Reflux Disease in Children: which Test for Symptomatic Correlation? J 
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ABSTRACT 
Objectives: To evaluate in children with chronic cough the prevalence of acidic GERD, and to 
establish if a temporal correlation exists using the traditional symptom (SI) and symptom sensitivity 
(SSI) indices and the new symptom association probability (SAP).  Methods: Distal esophageal 24-
hour pH monitoring was performed in 47 children (mean age ± SD: 34 ± 41 months, range: 1-108 
months; M/F: 27/20) affected by chronic unexplained cough. During recording time, caregivers 
documented each bought of coughing, both in a diary card and by pressing an event button on the 
digitrapper. Pathological reflux was defined as the percentage of time pH<4 exceeded 4%. SI, SSI, 
and SAP were calculated for each pH-tracing and considered positive if greater than 50%, 5%, and 
95%, respectively.  Results: GERD was diagnosed in 30 (64%) children with chronic cough, while 
one or more indices were positive in 16 (34%). In particular, SI was positive in 6 (13%) children 
(all with GERD), SSI in 12 (26%) (7 with GERD), while SAP was abnormal in 6 (13%) (4 with 
GERD). The Cohen’s kappa test reported a high agreement between SSI and SAP (k=0.60; 
p<0.0001)  and a poor one, between SI and SSI, and between SI and SAP (k=0.06 and k=0.24, 
respectively).  Conclusions: Children with chronic cough had a high prevalence of acidic GERD.  
Each of the three used indices identified a possible symptomatic association.  
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INTRODUCTION 
Cough is the most common presenting symptom to general practitioners in western societies 
(1).  Non-specific cough has been defined non-productive cough in the absence of identifiable 
respiratory disease or known aetiology (2).  Gastroesophageal reflux disease (GERD) is one of the 
three most common causes of chronic cough in children along with postnasal drip syndrome and 
asthma (3).  The cough, without associated heartburn or acid regurgitation, may be the only 
presenting manifestation of GERD in 10-45% of cases, in both prospective and retrospective studies 
(4-6).  However, few studies have examined whether a temporal correlation actually occurs between 
documented episodes of reflux and cough.   
In the diagnosis of GERD, ambulatory 24-hr esophageal pH monitoring is a valuable tool 
not only for the quantitative measurement of esophageal acid exposure but also for the assessment 
of the association in time between symptoms and reflux (7-9).  The most frequently used parameter 
in determining the significance of the symptom correlation on these pH tracings is currently the 
symptom index (SI), defined as the percentage of reflux related symptoms episodes (8).  The 
symptom-sensitivity index (SSI), defined as the percentage of symptom-associated reflux episodes 
was introduced as an additional parameter to overcome the drawbacks of the SI (9).  This index, 
however, fails to take into account the total number of symptom episodes, rendering its use of 
limited value.   
In suspected GERD patients, a consistent temporal association may clarify whether cough is 
induced by or provokes reflux and may help in the establishment of the appropriate treatment. The 
symptom association probability (SAP) is a single parameter which is able to provide more 
objective information on the probability that the association in time between reflux and symptoms 
does not occur by chance (10).   The aims of this study are: 1) to evaluate the prevalence of GERD 
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related to acid in children with chronic cough and 2) to establish if a temporal correlation exists 
between cough and GERD comparing the SI and SSI and the new SAP.  
 
SUBJECTS AND METHODS 
We prospectively investigated, from January 1 trough December 30, 2005, 47 consecutive 
patients (27 males; mean age ± SD: 34 ± 41 months, range 1-108 months) with chronic unexplained 
cough, referred for 24-h esophageal pH-monitoring to the Gastrointestinal Endoscopy and Motility 
Unit of the Department of Pediatrics, University “Federico II” of Naples, Italy.  
Chronic cough was defined as a cough which persisted greater than 3 weeks. 
Other causes of chronic cough were excluded.  All patients were 
immunocompetent, had a normal chest x-ray and asthma was excluded by negative 
spirometry and/or allergy testing and/or absence of improvement with antiasthmatic 
medication.  Postnasal drip syndrome was excluded both clinically and by sinus 
imaging.   
At enrollment, all patients underwent clinical evaluation and 24-hr esophageal pH-
monitoring.  If patients were receiving empirical antireflux therapy, acid suppressive medication 
was stopped at least two weeks before the 24-hr esophageal pH-monitoring.  A validated cough 
diary, using the verbal category descriptive score for daytime and nocturnal cough, was recorded by 
children’s caregiver, in order to obtain a measure of symptom severity and frequency (11). Cough 
was scored for each days as follows: 0, no cough; 1, cough for one or two short periods only; 2, 
cough for more than two short periods; 3, frequent coughing but does not interfere with school and 
other activities; 4 frequent coughing that interferes with school and other activities; and 5, cannot 
perform most activities due to severe coughing. A visual analogue scale from 0 to 10 was used for 
parental rating of cough severity and a full medical history was obtained for all patients at 
enrollment. 
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A one-channel esophageal pH probe (ambulatory system with semidisposable monocrystant 
antimony pH electrode,  Medtronic) was placed in all patients. Before each study, the pH electrode 
was calibrated in buffers of pH = 1.07 and pH = 7.01. The intraesophageal pH electrode was 
positioned 5 cm above the lower esophageal sphincter (LES), using Strobel's equation based on 
patient length (12).  Children’s caregivers were instructed to fill in a diary card the times of the 
meals, the sleeping periods and the onset of children’s bought of coughing, during the whole 
recording time. In addition, caregivers were given an event button for cough and were instructed on 
using it to indicate each time that a bought of coughing occurred. The diary data needed as a check 
of appropriate use of the event button. During the 24 hr examination the children were invited to 
perform a normal daily routine and eat normally. Patient data were stored in a portable disposable 
(Digitrapper Mk III, Medtronic), and the results for each day were analyzed subsequently using a 
specific software (Polygram for Windows, Medtronic). 
The following parameters were measured for each 24-hr tracing: 1) total reflux index (RI) = 
percent of investigation time with pH <4; 2) number of episodes with pH < 4; 3) number of 
episodes with pH < 4 lasting longer than 5 minutes: 4) duration of the longest episode with pH < 4. 
Reflux was considered pathological if the total time the pH was less than 4.0 exceeded  4.0 %.   
A clinician (GB) experienced in interpreting 24-hr pH tracings, who was blinded to the 
study, calculated the SI and SSI for each patient to establish whether a significant correlation 
between cough and reflux occurred.  The symptom index (SI) was defined as the number of reflux-
related cough episodes divided by the total number of cough episodes multiplied by 100 %.  The 
symptom sensitivity index (SSI) was defined as the number of cough-associated reflux episodes 
divided by the total number of reflux episodes multiplied by 100 %.  SI and SSI were calculated for 
each pH-tracing and were considered positive if greater than 50 % and 5 %, respectively. 
A separate investigator (FM) calculated the SAP for each patient using the following 
procedure adapted from Weusten et al (10).  The 24-hr esophageal pH signal was divided into 
consecutive 2-min periods.  Each period was then evaluated for the presence or absence of reflux. 
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 A drop in pH below 4.0 lasting at least 5 sec at any point during the 2-min window was considered 
positive for reflux. If cough occurred within a 2-min span, following reflux, the period was 
considered positive for both cough and reflux. Subsequently, a contingency table was constructed 
for each patient containing four fields (Table 1).  Fisher’s exact test was employed to calculate the 
probability (P value) that the observed association between reflux and symptoms occurred by 
chance.  The SAP was calculated as (1.0- P) x 100% and it was considered positive if greater than 
95 %. SAP values were compared with  SI and SSI previously calculated.   
Informed consent for participation in this study was obtained from parents of all patients, 
and the experimental design was approved by the Independent Ethics Committee of the University 
of Naples, Federico II. 
 
STATISTICAL ANALYSIS  
Continuous variables are expressed as mean +  standard deviation (SD). For categorical 
variable either the unpaired and paired t-test or the Fisher’s exact test were used, as appropriate.  To 
test the agreement among SI, SSI and SAP, Cohen’s k measure was applied. Statistical tests were 
performed with SPSS software, version 14.0.2. 
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RESULTS 
Esophageal pH monitoring was performed in all the 47 enrolled patients affected by chronic 
unexplained cough.  Three of them had received acid-suppressive therapy (ranitidine) at the dose of 
8 mg/Kg/day, for a period of 4 weeks, untill 2 weeks before the esophageal pH-monitoting was 
performed. No symptomatic remission was observed. GERD related to acid was diagnosed in 30 
(64%) children with chronic cough. The duration of esophageal pH-monitoring was not 
significantly different in children with GERD compared with children without GERD (mean + SD: 
22 + 1.23 hrs vs 22.3 + 1.3 hrs, respectively). Distribution at enrollment of the esophageal pH-
monitoring parameters and of the cough scores according to the acidic GERD positive (GERD +) 
and acidic GERD negative (GERD -) group of patients  are reported in Table 2.   
Cough severity and frequency, obtained using the cough score and the visual analogue 
scale, were significantly higher in children with GERD than in children without GERD. One or 
more indices were positive only in 16 (34%) out of 47 patient.  In particular, SI was positive in 6 
(13%) children (all with GERD), SSI in 12 (26%) (7 with GERD), while SAP was abnormal in 6 
(13%) (4 with GERD). Table 3 shows the distribution of the three symptomatic indices in children 
with chronic cough with and without GERD.   
The Cohen’s kappa test reported high agreement between SSI and SAP (k = 0.60;p< 0.0001), and 
poor agreement between SI and SSI, and between SI and SAP (k = 0.06 and k = 0.24, respectively).   
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DISCUSSION 
Chronic unexplained cough in children may be the only presenting manifestation of GERD 
in 45% of cases, in both prospective and retrospective studies (4-6,13).  In our study, GERD was 
diagnosed in 64% of children with chronic unexplained cough.  This higher prevalence is probably 
due to the fact that participants in our study were recruited from tertiary care settings and probably 
had more severe symptoms than general population.   
It has been shown that cough is associated with GERD, but there is conflicting data as to 
whether or not it is the consecutive factor (14, 15).  Cohort studies in adults suggest that GERD 
related to acid causes 21-41 % of chronic non-specific cough, including many patients with no 
gastrointestinal symptoms of GERD (16, 1).    Several possible mechanisms underlying a relation 
between reflux and respiratory symptoms have been proposed.  Heightened bronchial reactivity, 
microaspiration, and a vagally mediated reflex mechanism are possible pathways (17).  Exposure to 
small amounts of acid has recently been proposed as a cause of impaired laryngopharyngeal 
sensitivity and therefore may potentially increase the risk of aspiration (18). However, it has also 
been suggested that asthma causes or aggravates reflux (13).    
While the association between respiratory symptoms and GERD has been well demonstrated 
in adults, until now it has been unclear in children (19).   In pediatric literature, studies on chronic 
unexplained cough and GERD are scarce and include one prospective study, one retrospective study 
and various observational studies (20-25). The only pediatric  RCT study  evaluated whether cough 
frequency was increased by the thickening of infant milk formula feedings. It demonstrated an 
increased cough in infants with atypical GER (26). One case report documented a temporal 
association of gastroesophageal reflux episodes and cough in infants (27). Our study is the first 
prospective randomized evaluation of temporal correlation between GERD and chronic unexplained 
cough in a large group of children.  In contrast, many pediatric studies focused on the association 
between asthma and GERD. A high percentage of children with persistent asthma have 
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gastroesophageal reflux detectable by abnormal esophageal pH monitoring.  The reported 
prevalence ranges from 25 % to 75 %.  However, in children there is no consistent evidence that 
specific asthma symptoms or response to asthma therapy correlates with abnormal esophageal pH 
monitoring (28, 29).     
In children with atypical GERD, defined by the presence of extra-intestinal symptoms such 
as cough, 24-hr pH recording is the gold standard for correlating the acid reflux with cough, 
according to the most recent guidelines; however, evidence for this correlation is still lacking (30). 
We found  acidic GERD  in 64% of  children with chronic unexplained cough and each of the three 
symptomatic indices identified a possible temporal association.  In adults Wunderlich et al.(31) 
examined how a temporal correlation could often be found between coughing episodes and acid 
reflux events. They than compared the traditional method of analysis, which involves SI and SSI, 
and the potentially more precise SAP method revealing a significant number of patients with a 
temporal correlation between cough and reflux.   In fact, in adults, it has been well documented that 
although SI and SSI are not effective indicators of correlation between respiratory symptoms and 
gastroesophageal reflux episodes, SAP seems to be a more reliable statistical tool in the diagnosis of 
atypical GERD.  This was why we evaluated the effectiveness  of all these indices.  In our study SI 
was found to be positive in 13% of children (all with GERD), SSI in 26% of children (7 with 
GERD) and SAP was abnormal in just 13% of children (4 with GERD).  In particular, we found 
high agreement between SSI and SAP, and poor agreement between SI and SAP.   SI is defined as 
the number of reflux-related symptom episodes divided by the total number of symptom episodes 
multiplied by 100%. However, one major drawback of this parameter, is that it does not take into 
account the total number of reflux  episodes. The higher the frequency of reflux episodes, the 
greater the chance that a symptom will have a temporal correlation  with reflux. Thus a patient with 
frequent reflux and only one episode of cough may have a positive SI by chance alone.  The lack of 
correlation between SI and SAP in our study may indicate that the number of symptom episodes 
experienced in this subgroup of patients was relatively low, making them more susceptible for 
  111 
random symptom-reflux association. This finding confirms the limited usefulness of SI, compared 
to SSI and SAP, in the evaluation of a temporal correlation between gastroesophageal reflux 
episodes and symptoms.   In our study, once again in contrast to what was reported in adults, none 
of the three indices proved to be accurate in proving a relationship between cough and GERD.  This 
may suggest that chronic unexplained cough in children is due to different pathogenetic 
mechanisms than in adults. It also suggests that though cough and GERD often co-exist in children, 
their association does not imply cause and effect.    
On the other hand, we know that esophageal 24-hr pH-monitoring only recognizes acid 
reflux, while in literature it has been reported that respiratory symptoms are mainly due to non-acid 
reflux. Esophageal pH-impedance, is able to detect acidic and non acidic reflux and could better 
evaluate the relationship between cough and GER but it is a method not yet validated in children. 
For this reason in our study we used  the esophageal 24-hr pH-monitoring, currently considered the 
gold standard for the diagnosis of atypical GERD in children (30). Future studies on the correlation 
between non acidic reflux and respiratory symptoms are of course auspicable, but only after a 
validation of esophageal impedance in the paediatric population with the availability of clear age–
related range of values for the detection of normal and abnormal condition. They should be double 
blind, randomised controlled, parallel designed with validated subjective and objective cough 
outcomes and also should ascertain the time needed to respond to therapy as well as assess acid 
and/or non acid reflux  while on therapy.  
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LIST OF ABBREVIATIONS 
GERD: gastroesophageal reflux disease 
SI: symptom index 
SSI:symptom sensitivity index 
SAP: symptom association probability 
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Table 1 . Model of the contingency table constructed for each patient 
C = cough; R= reflux 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cough +(C+)                     Cough-(C-) 
Reflux + (R+) C +R+ C-R+ R+ total 
Reflux- (R-) C+R- C-R- R- total 
 C+ total C- total total 
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Table 2.  Values of 24-hr pH monitoring  and symptomatic score in the 47 patients studied.  
 
(*G
ER
D=
Gast
roes
opha
geal 
reflu
x 
dise
ase) 
Data 
are expressed in mean + standard deviation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 *GERD 
positive 
N° patients(%)  
30 (64%) 
*GERD 
negative 
N° patients (%) 
17 (36%) 
P value 
Esophageal pH-measurements     
 Investigation time with pH <4 (%) 13.6 ±  12  1.56 ± 1.0 <0.001 
N° of episodes with pH < 4 251.8 +170.7 63.8 + 16.8 <0.05 
N° of reflux longer than 5 minutes  5.1 ± 0.94 0.34 ± 0.12 <0.0001 
    
Cough score  3.2 ± 1.1  1.1 ± 1.0 <0.01 
Visual analog scale  6 ± 2.08 2.1 ± 1.1 <0.001 
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Table 3.  Distribution of the 3 symptomatic correlation indices in children with chronic cough with 
and without gastroesophageal reflux disease (GERD). 
 
Pts. with GERD 
30 (100) 
Positivity to one or 
more indices 
Pts. without GERD  
17 (100) 
Positivity to one or 
more indices 
19 (63.3) - 12 (70.6) - 
7 (23.3) 4 SI, 3 SSI 3 (17.6) 3 SSI  
2 (6.7) 2 (SSI + SAP) 2 (11.8) 2 (SSI +SAP) 
2 (6.7) 2 (SI +SSI +SAP)  0 (0) - 
Data are expressed in Nrs(%) 
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CONCLUSIONS 
WHAT THESE STUDIES ADD TO THE CURRENT KNOWLEDGE AND WHAT ARE 
THE RECOMMENDATIONS FOR FUTURE RESEARCH. 
 
1)Ontogeny and normal physiology of the esophageal and gastrointestinal motility. 
 
a)Development of Esophageal Peristalsis in Preterm and Term Neonates. (Staiano A, Boccia 
G et al. Gastroenterology 2007;132:1718–1725) 
    
 
Our study represents the first application of high-resolution manometry to preterm and term 
neonates.  
High-resolution manometry, is an innovative methods for the study of esophageal motility,wherein 
recording sites are increased in number and spaced closely in the axial direction, and interpolation 
of pressure data across sites is accomplished to visualize better the spacetime relationships using 3 -
dimensional isobaric contour maps. 
We demonstrates that the development in esophageal peristalsis occurs through late gestation into 
term. The 3 segments responsible for intact peristalsis in older children and adults are found in all 
infants and can be identified in neonates as young as 27 weeks gestational age at examination.  
Differential development occurs, such that the second segment in the mid-esophagus (proximal 
smooth-muscle segment) is present in the majority of swallows in all preterm and term neonates 
while the other 2 segments at proximal and distal ends of the esophageal body lag behind, 
developing in tandem despite very different underlying control mechanisms.  
These findings suggest a teleologic role for the second segment, possibly in enhancing clearance 
and preventing GERD and its complications. 
The fact that only half of swallows show completely intact segmental architecture at term, however, 
indicates that development of esophageal peristalsis continues into infancy. 
 
Future research should address the following areas: 
1) The development of motor behaviour leading to the junction opening during a transient LES 
relaxation, (eg, crural diaphragm inhibition, esophageal shortening, and favourable pressure 
gradient between the stomach and esophagea lumen).  This investigations could be very important 
for the understanding of the patophysiology of gastroesophageal reflux in neonates and children in 
order to provide better targets for more tailored therapeutic interventions. 
2) Expanded investigation of the specific neuroendocrine pathways that control the three functional 
esophageal segments found using high resolution manometry 
3) Focus on identification of drug targets for esophageal motility disorders that could act selectively 
on the specific functional segment involved.  
 
 
2) Epidemiology and patophysiology of the main functional gastrointestinal disorders in 
children 
 
a)Functional defecation disorders in children: Rome II criteria vs Rome III and PACCT 
criteria. (Boccia et al. J Pediatr 2007;151:394-8) 
 
Our study was the first that evaluated the clinical applicability of PACCT and Rome III criteria for 
functional defecation disorders (FDDs) in children referred to a tertiary center for chronic 
constipation. The prevalence of FDDs was significantly higher when using the PACCT/Rome III 
criteria than when using the Rome II criteria.  
  134 
Because in our study such a high percentage of constipated children reported the symptoms of 
defecation with straining, scybalous pebble-like stools, and painful defecation, we suggested that 
these symptoms be added in any revised criteria. 
 
Future research should address the following areas:  
1) The applicability and validity of Rome III diagnostic criteria for FC and other FGIDs in 
unselected populations and in both general practice and research settings. 
2) The epidemiology, natural history and health care impact of pediatric FGIDs. 
 
b)Dyspeptic symptoms in children: the result of a constipation- induced “cologastric brake”? 
(Boccia et al. Clin Gatroenterol Hepatol,submitted with revisions, October 2007) 
 
In this prospective study we reported that most children with functional dyspepsia (FD) also have 
functional constipation (FC) associated with delayed gastric emptying, and that normalization of 
bowel habits after laxative therapy can improve dyspeptic symptoms and gastric emptying. The 
enterogastric feedback activated by faecal stasis in the rectum should be considered among the 
possible mechanisms involved  in the pathogenesis of dyspepsia. 
The study is unique in pediatrics; the resolution of dyspeptic symptoms and gastric abnormalities 
after constipation treatment and bowel habit normalization suggests that, in a specific subset of 
patients, dyspepsia may be not an independent clinical entity but a clinical variant of functional 
constipation. 
 This implies that 1)dyspeptic children should be always investigated for functional constipation 
through appropriate validate questionnaires;2) A therapeutic trial with osmotic laxative might be  
advisable in dyspeptic children for the resolution to solve upper gastrointestinal symptoms. 
 
Future research should address :  
1)The relation between specific cluster of symptoms and different pathophysiological mechanisms, in 
order to provide better targets for more tailored therapeutic interventions. 
2)More precise delineation of the relationships between sensorimotor dysfunction, individual 
symptoms, and individual FGIDs: conceivably, the clinical manifestations in FGID patients depend 
on the specific sensory and/or reflex pathways and territories affected. Improved symptom criteria, 
together with quantitative data relating to physiological dysfunction (eg, hypersensitivity, 
dysmotility, and reflex dysfunction), to mucosal inflammation/immune/endocrine activation and to 
autonomic dysfunction, and in the future to molecular risk factors, should enable better 
categorization of patient subgroups using techniques such as cluster analysis. More sophisticated 
techniques to assess compliance, wall tension, and accommodation and to assess more precisely the 
flow of luminal content and gas and the effects of dietary constituents on sensorimotor function are 
required. In this regard, the development of minimally or noninvasive techniques of investigation, 
which can function as true surrogate markers of sensorimotor dysfunction and which can be 
repeated in patients after various therapeutic maneuvers, is essential. 
 
 
 
3) Diagnosis  and treatment of  the main pediatric  gastrointestinal motility disorders. 
 
a)Segmental characteristics of esophageal peristalsis in pediatric patients.Staiano A, 
Boccia G et al. (Neurogastroenterol Motil. 2007 Nov 21; [Epub ahead of print]) 
 
 
In this report, we successfully applied for the first time high resolution manometry to a group of 
subjects representing the broad age range seen in paediatrics (from neonates to children) to examine 
  135 
the appearance of peristalsis using these techniques. The distinctive chain of pressure events that 
also characterizes oesophageal peristalsis in adults was present in all age groups with minimal 
variation in the relative location of defining landmarks along oesophageal length.  
The identification of peristaltic segments has several important clinical implications. From a clinical 
standpoint the HRM appearance of peristalsis as a chain of three pressure segments with inter-
segmental throughs, may facilitated recognition of normal and abnormal motor function. The 
distinctive peristaltic pattern also helps identify lower esophageal sphincter location. From an 
investigational standpoint, the segmental character to esophageal peristalsis should be taken into 
consideration in manometric 
investigation of all age groups in particular in testing pharmacological responses and evaluating 
clearance mechanisms. 
 Future research should address: 
1) The application of HRM for the study of other section of the gastrointestinal tract (such as the 
small intestine and the colon or rectoanal segments) 
1) The investigation of the specific neuroendocrine pathways that control the three functional 
esophageal segments. 
2) Focus on identification of drug targets for esophageal motility disorders that could act selectively 
on each of the three functional segment involved.  
 
 
 
 
b) Chronic Cough and Gastroesophageal Reflux Disease in Children: which Test for 
Symptomatic Correlation? (Boccia et al.J Pediatr (submitted with revisions, September 2007)) 
 
c)Maintenance Therapy for Erosive Esophagitis in Children, After Healing by Omeprazole: Is 
It Advisable? (Boccia et al. Am J Gastroenterol 2007;102:1–7) 
 
In this study children with erosive esophagitis grade 2 or 3 healed at three months with omeprazole 
1.4 mg/kg/day were randomized to 3 groups for a six-month maintenance period: omeprazole in 
half the healing dose, or ranitidine, or placebo. In all 3 groups, very few relapsed symptomatically 
or endoscopically during the randomized treatment phase, or off treatment at longer-term follow-up. 
Three months after the completion of the maintenance phase, i.e., at 1 yr after entry into the study 
12 (26%) patients had symptoms sufficiently mild to discontinue GERD therapy, and only 3 of 44 
patients (6.8%) reported GERD symptoms (mild) within 30 months after discontinuation of the 
trial. Only a couple 
patients reported a need for antacid use. 
The strengths of our study lie in the study’s prospective nature, its controlled and randomized 
character, and its relatively long duration of prospective follow-up.  
The low rate of relapse, even without maintenance treatment, suggests that different 
pathophysiologic 
pathways are probably involved in the mechanisms of GERD in children and that reflux in some 
children may by a transient condition. This findings has important implications for management of 
gERD in children.. 
The final message is to consider a less aggressive approach to pharmacotherapeutic maintenance of 
healed erosive esophagitis in children. This approach would have the merit of minimizing the 
potential risks of chronic acid-suppressive therapy that several studies have recently brought to light 
and it might also reduce the financial costs of GERD treatment, estimated at more than $9 billion 
per year in the United States in 2000. 
 
Future research should address: 
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1) The role, efficacy and safety of maintenance acid-suppressive therapy in those children who may 
be most apt to develop erosive esophagitis: those with chronic neurological disease, previous 
esophageal surgery, or chronic respiratory disease. These children have also been the most likely to 
develop complications of esophagitis (strictures, Barrett’s esophagitis, and adenocarcinoma) and 
thus probably the children whom more likely will need a chronic PPI maintenance. 
2) The existence of a “transient GERD” as a well defined entity and the possible 
pathophysiologycal mechanisms implicated.  
3) The role of acid hypersecretion rebound in the symptomatic relapse of children with GERD, after 
acid-suppressive treatment. 
 
d)Functional  gastrointestinal disorders in migrainous children: efficacy of flunarizine. 
(Boccia et al.Cephalalgia 2006;26:1214-1219.) 
 
 
In this study we reported that pediatric patients with a diagnosis of migraine show a large 
prevalence of FGIDs. I particular among FGIDs our patients reported functional abdominal pain 
and functional vomiting. These FGIDs associated with migraine appear to correlate with a 
prolonged gastric emptying time. Furthermore we foud that flunarizine (a calcium channel blocker 
normally used for the migraine profilaxis  ) decreased the frequency and duration of migrainous 
episodes as well as the gastrointestinal symptoms and gastric emptying time in children with 
migraine and associated FGIDs. 
 
 
Future research should address:  
1) Integration of CNS imaging technology and classic neurophysiologic and neuropharmacologic 
approaches for improved understanding of the neurobiology of 
the brain-gut axis. 
2. Continued mechanistic focus on the basic science of visceral hypersensitivity and pain that 
includes the molecular basis for peripheral sensitization of sensory receptors by inflammatory 
mediators, selectivity of central pain-related transmission pathways, and higherorder 
central processing of nociceptive information from the viscera. 
3. Expanded investigation of the neuroendocrine pathways, which connect the brain with the gut 
and are responsible for alteration of function during psychogenic stress. 
4. Application of genomic chip technology in searches for genetic polymorphisms in receptors, 
enzymes, and steps in signal transduction cascades in elements of the ENS. 
5. Focus on identification of drug targets on neural elements of the ENS and CNS and on non-
neural cell types, such as mast cells and enterochromaffin cells, 
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